论文部分内容阅读
Haissaguerre等于2 0 0 0年首次应用肺静脉隔离术(pul monaryveinisolation ,PVI)治疗阵发性心房颤动(房颤) ,现多用于治疗无器质性心脏病的阵发性房颤。但在非阵发性房颤及合并器质性心脏病的病人中的疗效尚不明确。本研究的目的在于评价PVI治疗阵发性、持续性、永久性房颤中
Haissaguerre is the first application of pulmonial isolation (PVI) for paroxysmal atrial fibrillation (atrial fibrillation) in 2000 and is currently used for the treatment of paroxysmal atrial fibrillation without organic heart disease. However, in patients with non-paroxysmal atrial fibrillation and organic heart disease in the efficacy is not clear. The purpose of this study was to evaluate the efficacy of PVI in the treatment of paroxysmal, persistent, and permanent atrial fibrillation